# Shenzhen 01 Life Science and Technology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shenzhen-01-life-science-and-technology-co

- Industry: Biotechnology
- Headquarters: Shenzhen, China
- Website: www.aimigene.com
- Total disclosed funding: $15M
- Latest round: Series B (Apr 21, 2023)
- Investors on record: 7

## About

Established in 2016 and based in Shenzhen, China, Shenzhen 01 Life Science and Technology Co., Ltd. is a medical company that provides disease clinical research and diagnosis and treatment solutions. In 2017, it launched a brand called Yinwei. In 2019, it has prepared a polymerization medical testing laboratory and a microbiological research and development laboratory. In 2021, its technology platform was established. In April 2023, Shenzhen 01 Life Science and Technology Co., Ltd. raised CNY 100 million in series B1 funding from new investors Green Future, Danen Ventures, returning investors Green Pine Capital Partners, Seas Capital.

The company engages in the development of disease solutions based on human micro-ecological technology. It is established a human data-driven microbiome resource development and application platform, which includes human flora genetic testing, big data analysis, high-throughput strain screening, multi-omics strain cultivation, strain genome analysis, strain metabolome analysis, strain process development, metabolite druggability evaluation, animal model development and application. Its drug pipelines include atopic dermatitis, acne, type 2 diabetes, obesity, and nonalcoholic fatty liver disease. And its drug pipelines have in the discovery phase.

## Funding rounds

- Series B, Apr 21, 2023, $15M — Green Pine Capital Partners, Danen Capital, Seas Capital, Green Future
- Series A, Sep 23, 2021 — Green Pine Capital Partners, Beyond Ventures, Seas Capital
- Series A, Apr 30, 2021 — Empower Investment, Beyond Ventures, Yuanzheng Investment, Seas Capital

## Investors

- Empower Investment (https://capitalatlas.ai/funds/empower-investment) — Series A
- Beyond Ventures — Series A
- Yuanzheng Investment — Series A
- Seas Capital (https://capitalatlas.ai/funds/seas-capital) — Series A, Series B
- Green Pine Capital Partners (https://capitalatlas.ai/funds/green-pine-capital-partners) — Series A, Series B
- Danen Capital (https://capitalatlas.ai/funds/danen-capital) — Series B
- Green Future — Series B